Journal of The American Medical Association,1979; 241(5): 489-494
On the Diagnosis and Treatment of Breast Cancer, By: Dr. Maurice S. Fox, Ph.D.
“…breast cancer mortality has remained unchanged for at least the past 40 years.”

Seminars in Oncology, New agents and new medical treatments for advanced breast cancer. 14:1 1987 Mar pg 34-64. By: Henderson IC, Hayes DF, Come S, Harris JR, Canellos G. “Most retrospective studies have failed to show that the survival of patients with advanced breast cancer has changed very much over the past 20-30 years.”

Annals of Oncology, 2002, Volume 13, Issue 2, Pages: 197-207, Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? By: F. Cardoso, A. Di Leo, C. Lohrisch, C. Bernard, F. Ferreira and M. J. Piccart.
“Despite almost 30 years of clinical cancer research, the true impact of second and subsequent lines of chemotherapy on the outcome of metastatic breast cancer patients, especially on the duration of survival, is still unknown.”

“The breast cancer mortality rate has remained stable for several decades…”

“Chemotherapy was introduced as an anticancer therapy in the 1950s and combination chemotherapy started to be routinely used in the 1970s. Surprisingly, more than half a century later, its true impact on MBC patients’ survival is still a matter of debate. There is a general consensus that the role of cytotoxic therapy in prolonging survival in MBC patients is modest, and that the efficacy of second and subsequent lines of chemotherapy, also called ‘salvage’ therapy regimens, is uniformly poor.” (See 1-4 below)

1. Muss HB, Case D, Richards F et al. Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. N Engl J Med 1991; 325: 1342–1348.
2. Nabholtz JM, Senn HJ, Bezwoda WR et al. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with MBC progressing despite previous anthracycline containing chemotherapy. J Clin Oncol 1999; 17: 1413–1424.
3. Sjostrom J, Blomqvist C, Mouridsen H et al. Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group. Eur J Cancer 1999; 35: 1194–1201.
4. Fossati R, Confalonieri C, Torri V et al. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 1998; 16: 3439–3460.

“Since treatment for MBC [Metastatic Breast Cancer] is not curative, QOL [Quality of Life] is an important issue to consider when selecting a treatment regimen…”

Der Spiegel, 2004, April 10, pages 160 -162
Poison-without benefit, By: Jörg Von Blech
“Survival rates have not improved over the past decades. Today’s patients die just as fast of their cancer as their fellow sufferers did 25 years ago.”

The Lancet, 1980 Mar 15;1(8168 Pt 1):580-2, Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. By: Powles et al. “Overall survival of patients with primary breast cancer has not improved in the past ten years, despite increasing use of multiple-drug chemotherapy for treatment of metastases. Furthermore, there has been no improvement in survival from first metastasis, and survival may even have been shortened in some patients given chemotherapy. …. Actuarial survival analysis … reveals no prolongation in overall survival, despite the increased use of multiple-drug chemotherapy for metastatic disease. The survival of the 78 patients who received chemotherapy from first detection of metastases (including single-agent chemotherapy) was no better than that of the 80 who did not receive chemotherapy. There was also no improvement in survival for those who received multiple-drug chemotherapy (66 patients)…. The fact that regressions of breast cancer had no influence on overall survival must reflect the inadequacy of present-day chemotherapy.”

Breast Cancer Research and Treatment,1981, Volume 1, Issue 4, pp 357-363
Effect of chemotherapy on survival in metastatic breast cancer, By: Alexander H. G. Paterson M.D., et al. “…chemotherapy may be improving short-term survival in some patients, but is making no major impact on long-term survival.”

Cancer, 1986 Feb 1;57(3):567-70. Does more intense palliative treatment improve overall survival in metastatic breast cancer patients? By: Patel et al.
A retrospective review of 483 breast cancer patients treated between 1942 and 1975. It was found that despite a changing trend in therapy away from radiation and additive hormones towards chemotherapy and ablative hormones there was no increase in survival time from first diagnosis, or metastatic survival time, (from appearance of first metastasis).

Journal of Cancer Research and Clinical Oncology, No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapy, April 1988, Volume 114, Issue 2, pp 183-185, By: E. Petru, D. Schmähl
9350 Women were studied over an 11 year period. There were 40 different 1st line drug combinations used and 50 different 2nd line drug combinations.
“Our special aim was to evaluate combination chemotherapy and its influence on overall survival in late stage breast cancer patients. No significant improvement in overall survival times was found in the selected group of patients who were treated with intense palliative chemotherapy.”
“We think that from the ethical point of view it seems problematic to apply aggressive chemotherapy programs to patients with metastatic disease, since no significant therapeutic effect in terms of prolongation of life-span can be assumed.”

British Journal of Cancer, Does chemotherapy improve survival in advanced breast cancer? A statistical review, 1988; 57: pages 615–618. By: A’Hern, Ebbs, & Baum.
“Treatment attempts to prolong survival but trials rarely demonstrate a statistically significant survival advantage: it has been argued that chemotherapy does not prolong survival.”

South African Medical Journal, 2011, Vol. 101, No. 11
Genetic profiling in breast cancer, By: Edge & Panieri
“Of women with early breast cancer who receive chemotherapy 70 – 80% do not benefit from the treatment…”

Journal of Clinical Oncology, A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. vol.9, No.2, 1991, pp.: 305-312, By: The French Epirubicin Study Group.
“The two trials gave comparable results; in both studies, the response rates were not different for the two regimens, and no differences were observed in duration of response, time to progression, and survival.”

Cancer, A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma,1992 Jan 15;Vol 69, No.2, pages:476-81. By: Walters, Frye, Buzdar, Holmes & Hortobagyi. 67 breast cancer patients were included in this study.
“Unfortunately, although there were fewer toxic effects, disease progression did not allow the administration of more therapy; therefore, remission duration, time to progression, and survival rate were not prolonged significantly.” (Too many patients died)

Journal of Clinical Oncology, A decade of breast cancer clinical investigation: results as reported in the Program/ Proceedings of the American Society of Clinical Oncology. September 1994 vol. 12 no. 9 pages: 1789-1795, By: R T Chlebowski and L M Lillington
“These results suggest that a critical process evaluation of current policy and procedures involved in directing breast cancer research is warranted, especially for strategies in advanced disease. . . trials of advanced breast cancer therapy have remained relatively small and have consistently failed to support study hypotheses or identify successful new management approaches as defined by a significant impact on patient survival. . . Is it prudent, or even ethical, to continue to conduct clinical trials in advanced breast cancer populations based on demonstrably unreasonable assumptions of the anticipated magnitude of benefit?”

British Journal of Cancer, High-dose chemotherapy of metastatic breast cancer: the end of the beginning? 1997; 75(4): 467–469. By: J. Crown “The survival impact of chemotherapy in metastatic breast cancer is limited, and the disease remains essentially incurable.”

Annals of Oncology, 2012, no. 23; pages 547–555. Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? By: J. T. Ribeiro et al.
Conclusion: “Toxicity and chemotherapy resistance are still major limitations in the treatment of patients with MBC (Metastatic Breast Cancer). Further research into new cytotoxic compounds is needed in order to maximise benefit, whilst minimising toxicity.” It concludes with, “The main issue is still toxicity, as most of the compounds tested have displayed, at best, a distinct adverse event profile.”

Journal of the American Medical Association, September 4, 1991, Vol 266, No. 9.
The Evolution of Breast Cancer Treatment, By: Dr. Edward F. Scanlon, M.D., Former president of the American Cancer Society and professor emeritus of surgery at Northwestern University Medical Center. “over a period of 100 years, breast cancer treatment has evolved from no treatment to radical treatment and back again to more conservative management, without having affected mortality.”


The Oncologist, 2005;10(suppl 3):20–29 By: Joyce O’Shaughnessy
Baylor-Sammons Cancer Center, Dallas, Texas, USA
Extending Survival with Chemotherapy in Metastatic Breast Cancer
Metastatic breast cancer (MBC) remains essentially incurable…In the treatment of MBC, there is an underlying assumption that improvements in overall response rates would translate into long-term survival benefits. While there is indirect evidence to support a relationship between response and overall survival, few randomized trials have provided direct evidence.

The assessment of the *true survival benefits from chemotherapy in MBC can be difficult, given the potential for confounding issues, such as the impact of subsequent therapies.

*”True survival benefits”… Is the patient alive and healthy?

Cancer Treatment Reviews, Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. (2000), 26 (3), pp. 151-168. By: Stockler M., Wilcken N.R.C., Ghersi D., Simes R.J. “Metastatic breast cancer is incurable….” as well as, “There is little evidence-based consenus on when to use which treatments, in what combination and for how long.” [Since you say incurable, why would you put people through the hell of chemotherapy?]

Journal of Clinical Oncology, 2003; vol. 21 no. 6: p 959-962
Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer? By: Valero and Hortobagyi
This editorial by Valero and Hortobagyi reviews all of the large, prospective, randomized trials published comparing the newer, taxane-based chemotherapy regimens. These authors conclude that none of these regimens have increased either complete response rates or overall survival, with median survivals remaining at 2 years or less, or precisely the same results which were being obtained 30 years ago.

British Medical Journal, May 4, 2002; 324(7345): 1088–1092.
Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer. By: H Gilbert Welch, professor of medicine and Juliana Mogielnicki, research assistant. “Few stories in medicine are as sobering as the American experience with autologous bone marrow transplantation (ABMT) for treating breast cancer. It is a story of young women dying from aggressive disease, well meaning physicians trying to be equally aggressive in treating it, and lawyers arguing that insurers should pay the bill. It is also a story of professional interests, weak research, financial gain, politics, and fraud. Because of its potential relevance to complex cancer therapies currently in development (such as gene therapy) we recount here the story and its lessons.”

European Journal of Cancer, 2004 Mar;40(4):536-42.
Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Fumoleau P1, Largillier R, Clippe C, Dièras V, Orfeuvre H, Lesimple T, Culine S, Audhuy B, Serin D, Curé H, Vuillemin E, Morère JF, Montestruc F, Mouri Z, Namer M. “The inconvenience and toxicity associated with the administration of multiple i.v. agents present significant and possibly prohibitve drawbacks to their use in heavily pretreated patients for whom *palliation and maintenance of QOL[Quality Of Life] are the primary goals of treatment.” *(Patients with terminal diseases usually need palliation. It’s a kind of care that is supposed to make you feel better, even though it can’t cure you. How many people going through chemotherapy say they feel better?)

The American Journal of Oncology Review, vol. 1 (3):169-70, 2002
Chemotherapy in the treatment of patients with metastatic breast cancer: high-dose, low-dose — what have we accomplished? By: Dr. Lawrence N. Shulman, M.D., Vice Chair for Clinical Services/Adult Oncology, Dana-Farber Cancer institute (Harvard Medical School), Boston “[over the past 20 years]… We relentlessly combined chemotherapy agents in various regimens, with ever-increasing dose intensity…as seen in this compilation of data, the survival for patients participating in these studies is exactly the same, less than 2 years. These four studies are a snapshot of hundreds of studies done throughout the world, spanning 30 years, utilizing innumerable combinations of standard dose chemotherapy without a hint of significantly improved survival..”

Health Affairs, The Controversy Over High-Dose Chemotherapy With Autologous Bone Marrow Transplant For Breast Cancer By: Michelle M. Mello and Troyen A. Brennan, September 2001 vol. 20 no. 5 101-117.
“HDC [High Dose Chemotherapy] gives the patient a concentrated dose of cancer-fighting drugs that have the effect of destroying the patient’s immune system…In the 1990s more than 41,000 patients underwent high-dose chemotherapy plus autologous bone marrow transplant (HDC-ABMT) for breast cancer, despite a paucity [deficiency] of clinical evidence of its efficacy…The results of five recent major randomized trials showed that HDC-ABMT offers no advantage over standard-dose treatment for breast cancer.

AP News, FDA: Avastin should not be used for breast cancer
Dr. Albert Braverman, M.D., chief of oncology at State University of New York Downstate Medical Center referring to Avastin for breast cancer. “The bottom line is that it doesn’t work very well, I’ve seen the occasional patient have a brief remission, which is nice, but it’s certainly not doing anything important. It’s not saving anyone’s life…I think a few years down the line it was becoming increasingly clear, at least to me, that this wasn’t a particularly active drug, despite the initial presentation…But people are sort of on a roll and it takes a while for things to die down.”

Austral – Asian Journal of Cancer, Vol. 4, No.4, October 2005. Surgery: A New Candidate to Explain
Breast Cancer Paradoxes? By: Riccardo Ponzone, M.D., Ph.D.
“…the principle of indiscriminate cell-kill by chemotherapy is a path that will take to nowhere…Furthermore, the “sleepy” attitude of single disseminated cells who early colonise distant organs through the lymphatic or vascular circulation, should discourage everyone from thinking that they can be eradicated with conventional chemotherapy.”

Breast Cancer Research & Treatment, (2011) 130:345–351
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era, by: IC Chen et al.
“Tumor response to systemic chemotherapy remains generally poor for MCB patients…According to our single-institute retrospective study, the response of MCB to systemic chemotherapy remains poor in the modern era.”

The Lancet, 1998; 352: 515–21. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
By: Rodenhuis et al.
“Since high-dose adjuvant therapy did not even yield minimum evidence of a survival advantage over optimum conventional therapy and was associated with severe toxic effects, we strongly believe that this therapy should be given only in the setting of a randomised clinical trial.”

how-effective-is-chemotherapy-for-most-patientsHow effective is chemotherapy for most patients

high-priced-chemo-limited-benefit-youre-deadHigh priced chemo limited benefit YOURE DEAD

oncology-mindsetOncology Mindset

chemo-radiation-and-surgery-are-largely-ineffectiveChemo Radiation and Surgery are largely ineffective

all-chemotherapy-agents-are-carcinogenicsAll chemotherapy agents are carcinogenics

is-chemotherapy-harmful-to-the-immune-systemIs chemotherapy harmful to the immune system

does-it-make-sense-to-use-carcinogens-to-treat-cancerDoes it make sense to use carcinogens to treat cancer

am-i-doing-what-is-best-for-the-patientAm I doing what is best for the patient

audio-after-3-rounds-of-chemo-failure-a-4th-round-is-just-stupidAfter 3 rounds of chemo failure a 4th round is just stupid

cbs-news-optimism-about-chemoCBS news optimism about chemo

chemo-journeyChemo Journey

chemo-kills-just-as-many-people-as-cancerChemo Kills Just as Many People as Cancer

chemo-scientific-american-john-cairnsChemo Scientific American John Cairns

chemo-and-radiation-are-killing-cancer-patientsChemo and radiation are killing cancer patients

chemo-and-radiation-are-non-specificChemo and radiation are non specific

chemo-is-carcinogenicChemo is carcinogenic

chemo-surgery-and-radiation-are-not-very-effectiveChemo surgery and radiation are not very effective

chemo-will-only-to-cure-2-percent-this-yearChemo will only to cure 2 percent this year

chemotherapy-chemist-secretsChemotherapy Chemist Secrets

chemotherapy-can-boost-cancer-growth-foxChemotherapy can boost cancer growth Fox

chemotherapy-is-not-effective-for-90-percent-of-cancersChemotherapy is Not Effective for 90 Percent of Cancers

chemotherapy-is-a-waste-of-moneyChemotherapy is a Waste of Money

dr-gonzalez-explains-why-chemo-is-so-ineffectiveDr Gonzalez Explains why chemo is so ineffective

is-chemo-really-97-percent-ineffectiveIs Chemo really 97 percent ineffective

dr-jimenez-chemo-3-percentDr Jimenez chemo 3 percent effective

dr-lodi-conventional-medicine-doesnt-workDr Lodi Conventional medicine doesnt work

chris-wark-chemotherapy-causes-more-cancerChris Wark Chemotherapy Causes More Cancer

dr-desaulniers-2-percent-chemo-effective-rateDr Desaulniers 2 percent chemo effective rate

even-us-doctors-buy-unapproved-and-fake-cancer-drugsEven US doctors buy unapproved and fake cancer drugs

chemo-drugs-threats-to-health-care-workersChemo Drugs Threats to Health Care Workers

chris-wark-medicine-is-not-science-basedChris Wark Medicine is NOT Science Based

chemotherapy-boosting-cancer-growthChemotherapy Boosting Cancer Growth

abc-news-the-prevalence-of-hospital-errorsABC news the prevalence of hospital errors

chemotherapy-really-is-poisonChemotherapy really is poison

cancer-drugs-are-very-expensiveCancer drugs are very expensive

does-chemo-cause-cancer-gonzalesDoes chemo cause cancer Gonzales

audio-cancer-docs-talk-about-ineffective-chemoAudio Cancer docs talk about ineffective chemo

60-minutes-the-fight-against-counterfeit-drugs60 Minutes the fight against counterfeit drugs

fda-has-never-approved-chemo-or-radiation-for-childrenFDA has never approved chemo or radiation for children

half-of-all-drugs-are-recalledHalf of all drugs are recalled

big-pharma-big-money_documentary-on-the-money-and-corruption-of-big-pharmaceutical-companiesWhy it is so hard to recover from chemo

blind-faith-in-science-is-often-misplacedBlind faith in science is often misplaced

abc-news-counterfeit-cancer-drugsABC news Counterfeit Cancer Drugs

be-confident-on-your-chosen-treatmentBe confident on your chosen treatment

blind-obedience-can-kill-you-question-your-doctorBlind obedience can kill you question your doctor


To access the site, you must agree to the following;

Terms of Use


Please read these Terms of Use carefully before accessing or using our website. By accessing or using any part of the site, you agree to be bound by these Terms of Use. If you do not agree to all the terms and conditions of this agreement, then you may not access the website or use any services.

This website is operated by private parties in the Republic of Panama. Throughout the site, the terms “we”, “us” and “our” refer to, which offers this website, including all information, tools and services available from this site to you, the user, conditioned upon your acceptance of all terms, conditions, policies and notices stated here.

You understand and agree that you are accessing a website registered, owned, and hosted in the Republic of Panama. Therefore, all issues of a legal nature fall under the jurisdiction of the Republic of Panama legal system.

You understand and agree that as an authorized user you may only access information to which you have the legal authority to view and use. will monitor and record activity on this system to protect the system and its information and may use that monitoring information for official administrative or legal purposes. You understand and agree that you are not permitted to record, screenshot, or disseminate any information contained on the website to any party for any purpose whatsoever, and as such, you agree not to engage in such banned activities.

You understand and agree that unauthorized use of the system such as gaining unauthorized access to data, changing data, causing harm to the system or its data, or misuse of components is prohibited and may result in criminal, civil, or administrative penalties.

You also understand that can suspend or stop your use of this system if suspects any unauthorized use of the system attributable to you has occurred.

Your access to and use of the site is conditioned on your acceptance of and compliance with these Terms. These terms apply to all visitors, users and others who access or use the site. By accessing or using the site, you agree to be bound by these Terms. If you disagree with any part of the following Terms of Use, then you may not access the site.

By visiting our site and/ or purchasing anything from us, you engage in our “Service” and agree to be bound by the following terms and conditions (“Terms of Use”, “Terms”), including those additional terms and conditions and policies referenced herein and/or available by hyperlink. These Terms of Use apply to all users of the site, including without limitation users who are browsers, vendors, customers, merchants, and/ or contributors of content.

Any new features or tools which are added to the current website shall also be subject to the Terms of Use. You can review the most current version of the Terms of Use at any time on this page. We reserve the right to update, change or replace any part of these Terms of Use by posting updates and/or changes to our website. It is your responsibility to check this page periodically for changes. Your continued use of or access to the website following the posting of any changes constitutes acceptance of those changes.



By agreeing to these Terms of Use, you represent that you are at least the age of majority in your state, province, country or city of residence, or that you are the age of majority in your state, province, country or city of residence and you have given us your consent to allow any of your minor dependents to use this site.

You may not use any of our website for any illegal or unauthorized purpose nor may you, in the use of the Service, violate any laws in your jurisdiction (including but not limited to copyright laws).

You must not transmit any worms or viruses or any code of a destructive nature.

A breach or violation of any of the Terms will result in an immediate termination of your Services.



We reserve the right to refuse service to anyone for any reason at any time.

You agree not to reproduce, duplicate, copy, sell, resell or exploit any portion of the Service, use of the Service, or access to the Service or any contact on the website through which the service is provided, without express written permission by us.

The headings used in this agreement are included for convenience only and will not limit or otherwise affect these Terms.

You understand and agree that this website is for information purposes only, and that by providing the information contained herein, we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. You understand and agree that before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

You understand and agree that the information on the site is presented for the sole purpose of disseminating health information for general educational purposes only. You understand and agree that if you think you may have a medical emergency, you should call your doctor or 911. You understand and agree that the information on this site is not intended or implied to be medical advice, and you understand and agree that the information does not constitute the provision or practice of medical, nursing, or professional health care advice or services. You understand and agree that you will not use the information on this site as a substitute for professional medical advice, diagnosis, or treatment. You understand and agree that you should always seek the advice of your physician or other qualified health care provider prior to starting any treatment or with any questions you may have regarding a medical condition.

You understand and agree that nothing contained on this site is intended to be or will be used by you for medical diagnosis or treatment. You understand and agree that you should never disregard professional medical advice or delay in seeking treatment based on the information contained on this site. You understand and agree that the service and any content or information contained on the site is provided on an ‘as is’ basis. You understand and agree that while efforts have been made to assure the accuracy of the information on this site, there is no guarantee that such information is accurate or up-to-date. You understand and agree that, except for information, products, or services clearly identified as being supplied by the site, the site does not operate, control, or endorse any information, products, or services on the internet, in any way.

In addition, access to this site constitutes acceptance and understanding of the following,

By accessing this system, you hereby acknowledge, consent, and agree to all listed provisions and consent to monitoring.

You understand and agree that any copyright laws pertaining to the ownership and reproduction of all data fall exclusively under Panamanian legal jurisdiction for

If you are a copyright holder, or a director, officer, owner, employee, agent, supplier, licensor, contributor, service provider, website hosting company, trade partner, heir or assign of a copyright holder and feel that you or anyone you are engaged in any form of relationship whatsoever may have rights to data as part of this site or related sites, your agreement with the terms of use constitutes the following agreement, which is mandatory in order to access the data contained on this site.

I do hereby declare, understand, agree and warrant that I am a copyright owner, or an authorized representative of a copyright owner of film, print, slide, movie, video, artwork, digital image, negatives or any other material in any format whatsoever (hereafter referred to as “COPYRIGHTED DATA”) which I believe to be, known to be, or suspect to be contained on the website.

I hereby freely grant a non-exclusive license to and its agents to reproduce these COPYRIGHT DATA in perpetuity, and I represent and warrant that I have the legal right and authority to grant such a license. I may at my discretion ask to be credited for my contribution or the contributor I represent to the site as a contributor whether this occurred with or without my knowledge, but even if I or the contributor I represent remains uncredited, this agreement shall survive since participation in the free flowing of information for the public at large is a paramount responsibility we all should share. Therefore, in the best interest of free-flowing information for the public at large, I am freely undertaking this agreement, and clearly warrant that I have the authority to do so. I agree to indemnify and hold harmless and any of its directors, officers, owners, employees, agents, suppliers, licensors, contributors, service providers, website hosting companies, trade partners, heirs and assigns from any and all liability, damages, and expenses (including reasonable actual attorney’s fees) that may incur as a result of use and publication of said material, including any claims brought by any person claiming an interest in the COPYRIGHTED DATA or their subject matter. I agree and warrant that anyone containing any format of data from contained in any medium outside of the website itself, is bound by this agreement, since acceptance of this agreement is the only way to legally access such data. In addition, I understand and agree that accessing or storing any format of data contained in any medium outside of the website where it is hosted, constitutes a violation of the copyright laws of Panama against the offending party. I understand and agree that if I copy, contain, possess, or transmit any such data from the site in any format outside of the website itself, that my possession of such materials is a violation of Panamanian laws, and I agree to destroy such data forthwith.



We are not responsible if information made available on this site is not accurate, complete or current. The material on this site is provided for general information only and should not be relied upon or used as the sole basis for making decisions without consulting primary, more accurate, more complete or more timely sources of information. Any reliance on the material on this site is at your own risk.

This site may contain certain historical information. Historical information, necessarily, is not current and is provided for your reference only. We reserve the right to modify the contents of this site at any time, but we have no obligation to update any information on our site. You agree that it is your responsibility to monitor changes to our site.



We reserve the right at any time to modify or discontinue the Service (or any part or content thereof) without notice at any time.

We shall not be liable to you or to any third-party for any modification, change, suspension or discontinuance of the Service.



Any use by you of optional tools offered through the site is entirely at your own risk and discretion and you should ensure that you are familiar with and approve of the terms on which tools are provided by the relevant third-party provider(s).

We may also, in the future, offer new services and/or features through the website (including, the release of new tools and resources). Such new features and/or services shall also be subject to these Terms of Use.



Certain content, products and services available via our Service may include materials from third-parties.

Third-party links on this site may direct you to third-party websites that are not affiliated with us. We are not responsible for examining or evaluating the content or accuracy and we do not warrant and will not have any liability or responsibility for any third-party materials or websites, or for any other materials, products, or services of third-parties.

We are not liable for any harm or damages related to the purchase or use of goods, services, resources, content, or any other transactions made in connection with any third-party websites. Please review carefully the third-party’s policies and practices and make sure you understand them before you engage in any transaction. Complaints, claims, concerns, or questions regarding third-party products should be directed to the third-party.



If, at our request, you send certain specific submissions (for example contest entries) or without a request from us you send creative ideas, suggestions, proposals, plans, or other materials, whether online, by email, by postal mail, or otherwise (collectively, ‘comments’), you agree that we may, at any time, without restriction, edit, copy, publish, distribute, translate and otherwise use in any medium any comments that you forward to us. We are and shall be under no obligation (1) to maintain any comments in confidence; (2) to pay compensation for any comments; or (3) to respond to any comments.

We may, but have no obligation to, monitor, edit or remove content that we determine in our sole discretion are unlawful, offensive, threatening, libelous, defamatory, pornographic, obscene or otherwise objectionable or violates any party’s intellectual property or these Terms of Use.

You agree that your comments will not violate any right of any third-party, including copyright, trademark, privacy, personality or other personal or proprietary right. You further agree that your comments will not contain libelous or otherwise unlawful, abusive or obscene material, or contain any computer virus or other malware that could in any way affect the operation of the Service or any related website. You may not use a false e-mail address, pretend to be someone other than yourself, or otherwise mislead us or third-parties as to the origin of any comments. You are solely responsible for any comments you make and their accuracy. We take no responsibility and assume no liability for any comments posted by you or any third-party.



Occasionally there may be information on our site or in the Service that contains typographical errors, inaccuracies or omissions that may relate to product descriptions, pricing, promotions, offers, product shipping charges, transit times and availability. We reserve the right to correct any errors, inaccuracies or omissions, and to change or update information or cancel orders if any information in the Service or on any related website is inaccurate at any time without prior notice (including after you have submitted your order).

We undertake no obligation to update, amend or clarify information in the Service or on any related website, including without limitation, pricing information, except as required by law. No specified update or refresh date applied in the Service or on any related website, should be taken to indicate that all information in the Service or on any related website has been modified or updated.



In addition to other prohibitions as set forth in the Terms of Use, you are prohibited from using the site or its content: (a) for any unlawful purpose; (b) to solicit others to perform or participate in any unlawful acts; (c) to violate any international, federal, provincial or state regulations, rules, laws, or local ordinances; (d) to infringe upon or violate our intellectual property rights or the intellectual property rights of others; (e) to harass, abuse, insult, harm, defame, slander, disparage, intimidate, or discriminate based on gender, sexual orientation, religion, ethnicity, race, age, national origin, or disability; (f) to submit false or misleading information; (g) to upload or transmit viruses or any other type of malicious code that will or may be used in any way that will affect the functionality or operation of the Service or of any related website, other websites, or the Internet; (h) to collect or track the personal information of others; (i) to spam, phish, pharm, pretext, spider, crawl, or scrape; (j) for any obscene or immoral purpose; or (k) to interfere with or circumvent the security features of the Service or any related website, other websites, or the Internet. We reserve the right to terminate your use of the Service or any related website for violating any of the prohibited uses.



We do not guarantee, represent or warrant that your use of our service will be uninterrupted, timely, secure or error-free.

We do not warrant that the results that may be obtained from the use of the service will be accurate or reliable.

You agree that from time to time we may remove the service for indefinite periods of time or cancel the service at any time, without notice to you.

You expressly agree that your use of, or inability to use, the service is at your sole risk. The service and all products and services delivered to you through the service are (except as expressly stated by us) provided ‘as is’ and ‘as available’ for your use, without any representation, warranties or conditions of any kind, either express or implied, including all implied warranties or conditions of merchantability, merchantable quality, fitness for a particular purpose, durability, title, and non-infringement.

In no case shall anyone affiliated with including our directors, officers, employees, affiliates, agents, contractors, interns, suppliers, service providers or licensors be liable for any injury, loss, claim, or any direct, indirect, incidental, punitive, special, or consequential damages of any kind, including, without limitation lost profits, lost revenue, lost savings, loss of data, replacement costs, or any similar damages, whether based in contract, tort (including negligence), strict liability or otherwise, arising from your use of any of the service or any products procured using the service, or for any other claim related in any way to your use of the service or any product, including, but not limited to, any errors or omissions in any content, or any loss or damage of any kind incurred as a result of the use of the service or any content (or product) posted, transmitted, or otherwise made available via the service, even if advised of their possibility. Because some states or jurisdictions do not allow the exclusion or the limitation of liability for consequential or incidental damages, in such states or jurisdictions, our liability shall be limited to the maximum extent permitted by law.

You understand and agree that no singular individual, group of individuals or entity in any form whatsoever is responsible or liable in any manner for any content generated on, for, or as a result of the existence of this site, since this is a community generated site. You understand and agree that as this is a community generated site, and as a result of this, there is no good way to control what users and contributors post on or through the sites and cannot be responsible for any offensive, inappropriate, obscene, unlawful, infringing or otherwise objectionable or even illegal user generated content you may encounter on the sites or, in connection with your use of the sites.

You understand and agree with the following statement made on behalf of, “We, on behalf of our directors, officers, employees, agents, suppliers, licensors, contributors and service providers, exclude and disclaim liability for any losses and expenses of whatever nature and howsoever arising including, without limitation, any direct, indirect, general, special, punitive, incidental or consequential damages; loss of use: loss of data; loss caused by a virus: loss of income or profit: loss of or damage to property: loss of life: claims of third parties: or other losses of any kind or character, or the inability to use, the site or the content even if we have been advised of the possibility of such damages or losses, arising out of or in connection with the use of this site or any web site with which it is linked.”



You agree to indemnify, defend and hold harmless and our parent, subsidiaries, affiliates, partners, officers, directors, agents, contractors, licensors, service providers, subcontractors, suppliers, interns and employees, harmless from any claim or demand, including reasonable attorneys’ fees, made by any third-party due to or arising out of your breach of these Terms of Use or the documents they incorporate by reference, or your violation of any law or the rights of a third-party.



In the event that any provision of these Terms of Use is determined to be unlawful, void or unenforceable, such provision shall nonetheless be enforceable to the fullest extent permitted by applicable law, and the unenforceable portion shall be deemed to be severed from these Terms of Use, such determination shall not affect the validity and enforceability of any other remaining provisions.



The obligations and liabilities of the parties incurred prior to the termination date shall survive the termination of this agreement for all purposes.

These Terms of Use are effective unless and until terminated by us. You may terminate use of the site, but this Terms of Use shall survive in perpetuity.

If in our sole judgment you fail, or we suspect that you have failed, to comply with any term or provision of these Terms of Use, we also may terminate this agreement at any time without notice and you will remain liable for all amounts due up to and including the date of termination; and/or accordingly may deny you access to our Services (or any part thereof).



The information supplied through this website, or by any representative or agent of Dr. Farrah, whether by telephone, in person verbal, email, letter, image, text, facsimile or any other conceivable form of communication, is for informational purposes only and does not constitute medical, legal or other professional advice. Health-related information provided through this website is not a substitute for medical advice and should not be used to diagnose or treat health problems or to prescribe any medical devices or other remedies. The receipt of any questions or feedback that you submit in any form to any Dr. Farrah medium does not create a professional relationship and does not create any privacy interests.
You agree to indemnify, defend and hold harmless and our parent, subsidiaries, affiliates, partners, officers, directors, agents, contractors, licensors, service providers, subcontractors, suppliers, interns and employees, harmless from any claim or demand, including reasonable attorneys’ fees, made by any third-party due to or arising out of your breach of these Terms of Service or the documents they incorporate by reference, or your violation of any law or the rights of a third-party.



These Terms of Use and any separate agreements whereby we provide you Services shall be governed by and construed in accordance with the laws of the Republic of Panama.



You can review the most current version of the Terms of Use at any time at this page.

We reserve the right, at our sole discretion, to update, change or replace any part of these Terms of Use by posting updates and changes to our website. It is your responsibility to check our website periodically for changes. Your continued use of or access to our website or the Service following the posting of any changes to these Terms of Use constitutes acceptance of those changes.



Questions about the Terms of Use should be sent to us at

Upon agreeing to these terms and conditions, you gain access to the website and assume total responsibility for any and all actions undertaken by you as a result of your access to the website. You agree and understand that the terms of this agreement shall be binding upon you, your respective heirs, successors, assigns and legal representatives. You understand and agree that all provisions of this Terms of Use agreement that by their nature should survive termination shall survive termination, including, without limitation, ownership provisions, warranty disclaimers, indemnity, licensing in perpetuity and limitations of liability.